“Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized Pilot Study in Mexican Patients” (2020) Journal of Renal and Hepatic Disorders, 4(1), pp. 22–30. doi:10.15586/jrenhep.2020.61.